Abstract
Background
Intracranial germ cell tumors (IGCTs) are a group of rare pediatric brain tumors which include various subtypes. The current understanding of the etiology of the tumors and their optimal management strategies remain controversial.
Data sources
The data on IGCTs were collected from articles published in the past 20 years, and the origin and etiology of IGCTs at molecular level as well as the relative roles of varied treatment strategies in different prognosis groups according to Matsutani’s classification were reviewed.
Results
Recent cellular and molecular evidence suggests that IGCTs may arise from the transformation of endogenous brain cells; and findings in the molecular characterization of IGCTs suggest roles of CCND2, RB1, and PRDM14 in the pathogenesis of IGCTs and identify the KIT/RAS and AKT1/mTOR pathways as potential therapeutic targets in future. According to Matsutani’s classification of IGCTs, the good prognosis group includes both germinomas and mature teratomas. For germinomas, both radiation alone and reduced-dose radiotherapy in combination with adjuvant chemotherapy are effective, while complete surgical excision is recommended for mature teratomas. In the intermediate prognosis group, immature teratoma has been successfully treated with gamma knife surgery. However, for intermediate prognosis IGCTs other than immature teratomas, gross total resection with adjuvant chemotherapy and radiotherapy or gamma knife surgery may be necessary to achieve cure. In the poor prognosis group, survival outcomes are unsatisfactory, and complete surgical resection combined with more intensive chemotherapy and radiotherapy remains the best available treatment option at this time.
Conclusions
IGCTs should be strictly classified according to their pathological categories before administering pathology-specific treatments. Although open microsurgical excision is the traditional surgical strategy for IGCTs, recent publications also support the role of endoscopic surgical options for pineal region IGCTs.
Similar content being viewed by others
References
Kochi M, Itoyama Y, Shiraishi S, Kitamura I, Marubayashi T, Ushio Y. Successful treatment of intracranial nongerminomatous malignant germ cell tumors by administering neoadjuvant chemotherapy and radiotherapy before excision of residual tumors. J Neurosurg 2003;99:106–114.
Zhang R, Shen WQ, Zhou LF. Primary pediatric central nervous system tumors statistic: study of 763 cases in a single institution. Zhonghua Yi Xue Za Zhi 2007;87:442–447. [In Chinese]
Nomura K. Overview of the general rules for clinical and pathological studies on brain tumors, published by the Committee of Brain Tumor Registry of Japan, and the Japanese Pathological Society in 2002. Nihon Rinsho 2005;63 Suppl 9:195–203. [In Japanese]
Wang HW, Wu YH, Hsieh JY, Liang ML, Chao ME, Liu DJ, et al. Pediatric primary central nervous system germ cell tumors of different prognosis groups show characteristic miRNome traits and chromosome copy number variations. BMC Genomics 2010;11:132.
McCarthy BJ, Shibui S, Kayama T, Miyaoka E, Narita Y, Murakami M, et al. Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registries. Neuro Oncol 2012;14:1194–1200.
Liang L, Korogi Y, Sugahara T, Ikushima I, Shigematsu Y, Okuda T, et al. MRI of intracranial germ-cell tumours. Neuroradiology 2002;44:382–388.
Matsutani M, Sano K, Takakura K, Fujimaki T, Nakamura O, Funata N, et al. Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. J Neurosurg 1997;86:446–455.
Hirato J, Nakazato Y. Pathology of pineal region tumors. J Neurooncol 2001;54:239–249.
Teilum G. Classification of endodermal sinus tumour (mesoblatoma vitellinum) and so-called "embryonal carcinoma" of the ovary. Acta Pathol Microbiol Scand 1965;64:407–429.
Damjanov I, Andrews PW. The terminology of teratocarcinomas and teratomas. Nat Biotechnol 2007;25:1212; discussion 1212.
Kim JB, Greber B, Arauzo-Bravo MJ, Meyer J, Park KI, Zaehres H, et al. Direct reprogramming of human neural stem cells by OCT4. Nature 2009;461:649–653.
Krag Jacobsen G, Barlebo H, Olsen J, Schultz HP, Starklint H, Sogaard H, et al. Testicular germ cell tumours in Denmark 1976-1980.Pathology of 1058 consecutive cases. Acta Radiol Oncol 1984;23:239–247.
Taccagni GL, Parafioriti A, Dell’Antonio G, Crespi G. Mixed germ cell tumour of the mediastinum (seminoma, embryonal carcinoma, choriocarcinoma and teratoma). Light and electron microscopic cytology and histological investigation. Pathol Res Pract 1989;185:506–510; discussion 511-503.
Bohara M, Hirano H, Tokimura H, Hanaya R, Yonezawa H, Campos F, et al. Pineal mixed germ cell tumor with a synchronous sellar lesion in the sixth decade. Brain Tumor Pathol 2011;28:163–166.
Akahira J, Ito K, Kosuge S, Konno R, Sato S, Yajima A, et al. Ovarian mixed germ cell tumor composed of dysgerminoma, endodermal sinus tumor, choriocarcinoma and mature teratoma in a 44-year-old woman: case report and literature review. Pathol Int 1998;48:471–474.
Rescorla FJ, Sawin RS, Coran AG, Dillon PW, Azizkhan RG. Long-term outcome for infants and children with sacrococcygeal teratoma: a report from the Childrens Cancer Group. J Pediatr Surg 1998;33:171–176.
Swamy R, Embleton N, Hale J. Sacrococcygeal teratoma over two decades: birth prevalence, prenatal diagnosis and clinical outcomes. Prenat Diagn 2008;28:1048–1051.
Okada Y, Nishikawa R, Matsutani M, Louis DN. Hypomethylated X chromosome gain and rare isochromosome 12p in diverse intracranial germ cell tumors. J Neuropathol Exp Neurol 2002;61:531–538.
Juric D, Sale S, Hromas RA, Yu R, Wang Y, Duran GE, et al. Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures. Proc Natl Acad Sci U S A 2005;102:17763–17768.
Losi L, Polito P, Hagemeijer A, Buonamici L, Van den Berghe H, Dal Cin P. Intracranial germ cell tumour (embryonal carcinoma with teratoma) with complex karyotype including isochromosome 12p. Virchows Arch 1998;433:571–574.
Terashima K, Yu A, Chow WY, Hsu WC, Chen P, Wong S, et al. Genome-wide analysis of DNA copy number alterations and loss of heterozygosity in intracranial germ cell tumors. Pediatr Blood Cancer 2014;61:593–600.
Schlembach D, Bornemann A, Rupprecht T, Beinder E. Fetal intracranial tumors detected by ultrasound: a report of two cases and review of the literature. Ultrasound Obstet Gynecol 1999;14:407–418.
Travis LB, Fossa SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, et al. Second cancers among 40, 576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 2005;97:1354–1365.
Wang L, Yamaguchi S, Burstein MD, Terashima K, Chang K, Ng HK, et al. Novel somatic and germline mutations in intracranial germ cell tumours. Nature 2014;511:241–245.
Nishikawa R, Matsutani M. Immunohistochemical analysis of p53 and p21(WAF1/Cip1) expression in primary intracranial germ cell tumors. Neurosurg Focus 1998;5:e2.
Franzini A, Leocata F, Servello D, Cajola L, Allegranza A, Broggi G. Long-term follow-up of germinoma after stereotactic biopsy and brain radiotherapy: a cell kinetics study. J Neurol 1998;245:593–597.
Ogawa K, Shikama N, Toita T, Nakamura K, Uno T, Onishi H, et al. Long-term results of radiotherapy for intracranial germinoma: a multi-institutional retrospective review of 126 patients. Int J Radiat Oncol Biol Phys 2004;58:705–713.
Maity A, Shu HK, Janss A, Belasco JB, Rorke L, Phillips PC, et al. Craniospinal radiation in the treatment of biopsy-proven intracranial germinomas: twenty-five years’ experience in a single center. Int J Radiat Oncol Biol Phys 2004;58:1165–1170.
Calaminus G, Bamberg M, Jurgens H, Kortmann RD, Sorensen N, Wiestler OD, et al. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89. Klin Padiatr 2004;216:141–149.
Bamberg M, Kortmann RD, Calaminus G, Becker G, Meisner C, Harms D, et al. Radiation therapy for intracranial germinoma: results of the German cooperative prospective trials MAKEI 83/86/89. J Clin Oncol 1999;17:2585–2592.
Calaminus G, Kortmann R, Worch J, Nicholson JC, Alapetite C, Garre ML, et al. SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro Oncol 2013;15:788–796.
Haas-Kogan DA, Missett BT, Wara WM, Donaldson SS, Lamborn KR, Prados MD, et al. Radiation therapy for intracranial germ cell tumors. Int J Radiat Oncol Biol Phys 2003;56:511–518.
Haddock MG, Schild SE, Scheithauer BW, Schomberg PJ. Radiation therapy for histologically confirmed primary central nervous system germinoma. Int J Radiat Oncol Biol Phys 1997;38:915–923.
Tseng CK, Tsang NM, Wei KC, Jaing TH, Pai PC, Chang TC. Radiotherapy to primary CNS germinoma: how large an irradiated volume is justified for tumor control? J Neurooncol 2003;62:343–348.
Shikama N, Ogawa K, Tanaka S, Toita T, Nakamura K, Uno T, et al. Lack of benefit of spinal irradiation in the primary treatment of intracranial germinoma: a multiinstitutional, retrospective review of 180 patients. Cancer 2005;104:126–134.
Sano K. Pathogenesis of intracranial germ cell tumors reconsidered. J Neurosurg 1999;90:258–264.
Ogawa K, Toita T, Nakamura K, Uno T, Onishi H, Itami J, et al. Treatment and prognosis of patients with intracranial nongerminomatous malignant germ cell tumors: a multiinstitutional retrospective analysis of 41 patients. Cancer 2003;98:369–376.
Selcuki M, Attar A, Yuceer N, Tuna H, Cakiroglu E. Mature teratoma of the lateral ventricle: report of two cases. Acta Neurochir (Wien) 1998;140:171–174.
Jakacki R. Central Nervous System Germ Cell Tumors. Curr Treat Options Neurol 2002;4:139–145.
da Silva NS, Cappellano AM, Diez B, Cavalheiro S, Gardner S, Wisoff J, et al. Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study. Pediatr Blood Cancer 2010;54:377–383.
Alapetite C, Brisse H, Patte C, Raquin MA, Gaboriaud G, Carrie C, et al. Pattern of relapse and outcome of non-metastatic germinoma patients treated with chemotherapy and limited field radiation: the SFOP experience. Neuro Oncol 2010;12:1318–1325.
Shibamoto Y, Takahashi M, Abe M. Reduction of the radiation dose for intracranial germinoma: a prospective study. Br J Cancer 1994;70:984–989.
Kumabe T, Kusaka Y, Jokura H, Ikeda H, Shirane R, Yoshimoto T. Recurrence of intracranial germinoma initially treated with chemotherapy only. No Shinkei Geka 2002;30:935–942. [In Japanese]
Aoyama H, Shirato H, Ikeda J, Fujieda K, Miyasaka K, Sawamura Y. Induction chemotherapy followed by low-dose involvedfield radiotherapy for intracranial germ cell tumors. J Clin Oncol 2002;20:857–865.
Fouladi M, Grant R, Baruchel S, Chan H, Malkin D, Weitzman S, et al. Comparison of survival outcomes in patients with intracranial germinomas treated with radiation alone versus reduced-dose radiation and chemotherapy. Childs Nerv Syst 1998;14:596–601.
Nguyen QN, Chang EL, Allen PK, Maor MH, Ater JL, Mahajan A, et al. Focal and craniospinal irradiation for patients with intracranial germinoma and patterns of failure. Cancer 2006;107:2228–2236.
Souweidane MM, Krieger MD, Weiner HL, Finlay JL. Surgical management of primary central nervous system germ cell tumors: proceedings from the Second International Symposium on Central Nervous System Germ Cell Tumors. J Neurosurg Pediatr 2010;6:125–130.
Bouffet E, Baranzelli MC, Patte C, Portas M, Edan C, Chastagner P, et al. Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience. Societe Francaise d’Oncologie Pediatrique. Br J Cancer 1999;79:1199–1204.
Balmaceda C, Heller G, Rosenblum M, Diez B, Villablanca JG, Kellie S, et al. Chemotherapy without irradiation—a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study. J Clin Oncol 1996;14:2908–2915.
Edwards MS, Hudgins RJ, Wilson CB, Levin VA, Wara WM. Pineal region tumors in children. J Neurosurg 1988;68:689–697.
Schild SE, Haddock MG, Scheithauer BW, Marks LB, Norman MG, Burger PC, et al. Nongerminomatous germ cell tumors of the brain. Int J Radiat Oncol Biol Phys 1996;36:557–563.
Packer RJ, Cohen BH, Cooney K. Intracranial germ cell tumors. Oncologist 2000;5:312–320.
Huang X, Zhang R, Mao Y, Zhou LF. Modified grading system for clinical outcome of intracranial non-germinomatous malignant germ cell tumors. Oncol Lett 2010;1:627–631.
Konovalov AN, Pitskhelauri DI. Principles of treatment of the pineal region tumors. Surg Neurol 2003;59:250–268.
Blakeley JO, Grossman SA. Management of pineal region tumors. Curr Treat Options Oncol 2006;7:505–516.
Matsutani M. Combined chemotherapy and radiation therapy for CNS germ cell tumors—the Japanese experience. J Neurooncol 2001;54:311–316.
Robertson PL, DaRosso RC, Allen JC. Improved prognosis of intracranial non-germinoma germ cell tumors with multimodality therapy. J Neurooncol 1997;32:71–80.
Kretschmar C, Kleinberg L, Greenberg M, Burger P, Holmes E, Wharam M. Pre-radiation chemotherapy with response-based radiation therapy in children with central nervous system germ cell tumors: a report from the Children’s Oncology Group. Pediatr Blood Cancer 2007;48:285–291.
Weiner HL, Lichtenbaum RA, Wisoff JH, Snow RB, Souweidane MM, Bruce JN, et al. Delayed surgical resection of central nervous system germ cell tumors. Neurosurgery 2002;50:727–733; discussion 733-724.
Huang X, Zhang R, Zhou LF. Diagnosis and treatment of intracranial immature teratoma. Pediatr Neurosurg 2009;45:354–360.
Kobayashi T, Kida Y, Mori Y. Stereotactic gamma radiosurgery for pineal and related tumors. J Neurooncol 2001;54:301–309.
Hasegawa T, Kondziolka D, Hadjipanayis CG, Flickinger JC, Lunsford LD. Stereotactic radiosurgery for CNS nongerminomatous germ cell tumors. Report of four cases. Pediatr Neurosurg 2003;38:329–333.
Endo H, Kumabe T, Jokura H, Tominaga T. Stereotactic radiosurgery followed by whole ventricular irradiation for primary intracranial germinoma of the pineal region. Minim Invasive Neurosurg 2005;48:186–190.
Tada T, Takizawa T, Nakazato F, Kobayashi S, Koike K, Oguchi M, et al. Treatment of intracranial nongerminomatous germ-cell tumor by high-dose chemotherapy and autologous stem-cell rescue. J Neurooncol 1999;44:71–76.
Al-Tamimi YZ, Bhargava D, Surash S, Ramirez RE, Novegno F, Crimmins DW, et al. Endoscopic biopsy during third ventriculostomy in paediatric pineal region tumours. Childs Nerv Syst 2008;24:1323–1326.
Yamini B, Refai D, Rubin CM, Frim DM. Initial endoscopic management of pineal region tumors and associated hydrocephalus: clinical series and literature review. J Neurosurg 2004;100:437–441.
Pople IK, Athanasiou TC, Sandeman DR, Coakham HB. The role of endoscopic biopsy and third ventriculostomy in the management of pineal region tumours. Br J Neurosurg 2001;15:305–311.
Ellenbogen RG, Moores LE. Endoscopic management of a pineal and suprasellar germinoma with associated hydrocephalus: technical case report. Minim Invasive Neurosurg 1997;40:13–15; discussion 16.
O’Brien DF, Hayhurst C, Pizer B, Mallucci CL. Outcomes in patients undergoing single-trajectory endoscopic third ventriculostomy and endoscopic biopsy for midline tumors presenting with obstructive hydrocephalus. J Neurosurg 2006;105:219–226.
Shono T, Natori Y, Morioka T, Torisu R, Mizoguchi M, Nagata S, et al. Results of a long-term follow-up after neuroendoscopic biopsy procedure and third ventriculostomy in patients with intracranial germinomas. J Neurosurg 2007;107:193–198.
Legault G, Allen JC. Potential role of ventricular tumor markers in CNS germ cell tumors. Pediatr Blood Cancer 2013;60:1647–1650.
Ono H, Shin M, Takai K, Oya S, Mukasa A, Saito N. Spontaneous regression of germinoma in the pineal region before endoscopic surgery: a pitfall of modern strategy for pineal germ cell tumors. J Neurooncol 2011;103:755–758.
Gangemi M, Maiuri F, Colella G, Buonamassa S. Endoscopic surgery for pineal region tumors. Minim Invasive Neurosurg 2001;44:70–73.
Thaher F, Kurucz P, Fuellbier L, Bittl M, Hopf NJ. Endoscopic surgery for tumors of the pineal region via a paramedian infratentorial supracerebellar keyhole approach (PISKA). Neurosurg Rev 2014;37:677–684.
Luther N, Edgar MA, Dunkel IJ, Souweidane MM. Correlation of endoscopic biopsy with tumor marker status in primary intracranial germ cell tumors. J Neurooncol 2006;79:45–50.
Azab WA, Nasim K, Salaheddin W. An overview of the current surgical options for pineal region tumors. Surg Neurol Int 2014;5:39.
Wolden SL, Wara WM, Larson DA, Prados MD, Edwards MS, Sneed PK. Radiation therapy for primary intracranial germ-cell tumors. Int J Radiat Oncol Biol Phys 1995;32:943–949.
Shinoda J, Sakai N, Yano H, Hattori T, Ohkuma A, Sakaguchi H. Prognostic factors and therapeutic problems of primary intracranial choriocarcinoma/germ-cell tumors with high levels of HCG. J Neurooncol 2004;66:225–240.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huang, X., Zhang, R., Mao, Y. et al. Recent advances in molecular biology and treatment strategies for intracranial germ cell tumors. World J Pediatr 12, 275–282 (2016). https://doi.org/10.1007/s12519-016-0021-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12519-016-0021-2